b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">30838312</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>10</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Electronic">2330-1619</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>6</Volume>\n                    <Issue>2</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Feb</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Movement disorders clinical practice</Title>\n                <ISOAbbreviation>Mov Disord Clin Pract</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Comparing Risperidone and Olanzapine to Tetrabenazine for the Management of Chorea in Huntington Disease: An Analysis from the Enroll-HD Database.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>132-138</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/mdc3.12706</ELocationID>\n            <Abstract>\n                <AbstractText Label="Introduction" NlmCategory="UNASSIGNED">Huntington\'s chorea (HC) is commonly managed with neuroleptic medications, though there is little evidence to support their use. This study aimed to perform a real-world comparison of the efficacy of risperidone and olanzapine to tetrabenazine (TBZ) for HC.</AbstractText>\n                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">The Enroll-HD database was used to perform a propensity score-matched comparison of risperidone and olanzapine to TBZ, regarding their efficacy in controlling chorea. Participants with motor manifest Huntington\'s disease (HD) were grouped according to their use of risperidone, olanzapine, or TBZ. For the three groups, independent propensity score matching was performed on participants\' baseline total functional score (TFC), baseline total motor score (TMS), disease burden score, CAG repeat length, baseline age, region, sex, and body mass index. Independent samples <i>t</i> test was used to calculate the differences between the groups in the annual rate of change of the TMS from the baseline to the second available visit.</AbstractText>\n                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The risperidone (n\xe2\x80\x89=\xe2\x80\x8972) and olanzapine groups (n\xe2\x80\x89=\xe2\x80\x8977) had annualized increases (worsening) in the TMS of only 1.47 points and 3.20 points, respectively, compared to 5.70 points in the two matched TBZ groups (n\xe2\x80\x89=\xe2\x80\x8972) (<i>P</i>\xe2\x80\x89=\xe2\x80\x890.019) and (n\xe2\x80\x89=\xe2\x80\x8977) (<i>P</i>\xe2\x80\x89=\xe2\x80\x890.143), respectively.</AbstractText>\n                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">In the absence of prospective data, this analysis of the Enroll-HD database found that the neuroleptics risperidone and olanzapine seemed to at least be comparable to TBZ at controlling HC. These results demonstrate that neuroleptics may have comparable efficacy to TBZ for the treatment of HC. Further prospective studies are needed to confirm these findings.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Schultz</LastName>\n                    <ForeName>Jordan L</ForeName>\n                    <Initials>JL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Psychiatry The University of Iowa Hospitals and Clinics Iowa City IA United States.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology The University of Iowa Hospitals and Clinics Iowa City IA United States.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmaceutical Care The University of Iowa Hospitals and Clinics Iowa City IA United States.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kamholz</LastName>\n                    <ForeName>John A</ForeName>\n                    <Initials>JA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Psychiatry The University of Iowa Hospitals and Clinics Iowa City IA United States.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology The University of Iowa Hospitals and Clinics Iowa City IA United States.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Nopoulos</LastName>\n                    <ForeName>Peg C</ForeName>\n                    <Initials>PC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Psychiatry The University of Iowa Hospitals and Clinics Iowa City IA United States.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology The University of Iowa Hospitals and Clinics Iowa City IA United States.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Stead Family Department of Pediatrics The University of Iowa Hospitals and Clinics Iowa City IA United States.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Killoran</LastName>\n                    <ForeName>Annie</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology The University of Iowa Hospitals and Clinics Iowa City IA United States.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>The Veteran\'s Affairs Medical Center Iowa City IA United States.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>30</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Mov Disord Clin Pract</MedlineTA>\n            <NlmUniqueID>101630279</NlmUniqueID>\n            <ISSNLinking>2330-1619</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Enroll\xe2\x80\x90HD</Keyword>\n            <Keyword MajorTopicYN="N">Huntington\'s disease</Keyword>\n            <Keyword MajorTopicYN="N">chorea</Keyword>\n            <Keyword MajorTopicYN="N">olanzapine</Keyword>\n            <Keyword MajorTopicYN="N">risperidone</Keyword>\n            <Keyword MajorTopicYN="N">tetrabenazine</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>04</Month>\n                <Day>16</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>09</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30838312</ArticleId>\n            <ArticleId IdType="doi">10.1002/mdc3.12706</ArticleId>\n            <ArticleId IdType="pii">MDC312706</ArticleId>\n            <ArticleId IdType="pmc">PMC6384174</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Sleep Med Rev. 2017 Jun;33:51-57</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27321864</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):209-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14742590</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Affect Disord. 2013 Oct;151(1):248-58</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23876196</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 2018 Jul 17;91(3):e202-e207</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29925548</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mov Disord. 2014 Sep 15;29(11):1404-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25164707</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA. 2016 Jul 5;316(1):40-50</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27380342</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mov Disord. 2013 Jul;28(8):1030-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23674480</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CPT Pharmacometrics Syst Pharmacol. 2016 Aug;5(8):437-45</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27481337</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMC Neurol. 2009 Dec 18;9:62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20021666</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 2006 Feb 14;66(3):366-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16476934</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Clin Psychiatry. 2008 Jan-Mar;20(1):1-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18297579</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Psychopharmacol. 2004 Feb;24(1):62-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14709949</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2014 Jan 15;9(1):e85430</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24454865</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nutrition. 2004 Feb;20(2):192-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14962685</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drugs. 2017 Jan;77(1):29-46</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27988871</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Neuropharmacol. 2008 Nov-Dec;31(6):313-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19050408</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mov Disord. 1996 Mar;11(2):136-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8684382</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurol. 2016 Oct;263(10):2080-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27435968</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mov Disord Clin Pract. 2016 Jun 22;4(2):212-224</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30363395</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Neurol. 2017 Sep;82(3):479-483</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28779551</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS Curr. 2011 Aug 30;3:RRN1260</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21975581</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Multivariate Behav Res. 2011 May;46(3):399-424</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21818162</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'